Unveiling E2F4, TEAD1 and AP-1 as regulatory transcription factors of the replicative senescence program by multi-omics analysis

Abstract

Senescence, a stable state of growth arrest, affects many physiological and pathophysiological processes, especially aging. Previous work has indicated that transcription factors (TFs) play a role in regulating senescence. However, a systematic study of regulatory TFs during replicative senescence (RS) using multi-omics analysis is still lacking. Here, we generated time-resolved RNA-seq, reduced representation bisulfite sequencing (RRBS) and ATAC-seq datasets during RS of mouse skin fibroblasts, which demonstrated that an enhanced inflammatory response and reduced proliferative capacity were the main characteristics of RS in both the transcriptome and epigenome. Through integrative analysis and genetic manipulations, we found that transcription factors E2F4, TEAD1 and AP-1 are key regulators of RS. Overexpression of E2f4 improved cellular proliferative capacity, attenuated SA-β-Gal activity and changed RS-associated differentially methylated sites (DMSs). Moreover, knockdown of Tead1 attenuated SA-β-Gal activity and partially altered the RS-associated transcriptome. In addition, knock-down of Atf3, one member of AP-1 superfamily TFs, reduced Cdkn2a (p16) expression in pre-senescent fibroblasts. Taken together, the results of this study identified transcription factors regulating the senescence program through multi-omics analysis, providing potential therapeutic targets for anti-aging.

Keywords

transcription factor / senescence / multi-omics

References

[1] Avelar RA, Ortega JG, Tacutu R, Tyler EJ, Bennett D, Binetti P, Budovsky A, Chatsirisupachai K, Johnson E, Murray A et al (2020) A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol 21: 91

[2] Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, Saltness RA, Jeganathan KB, Verzosa GC, Pezeshki A et al (2016) Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530: 184- 189

[3] Berest I, Arnold C, Reyes-Palomares A, Palla G, Rasmussen KD, Giles H, Bruch PM, Huber W, Dietrich S, Helin K et al (2020) Quantification of differential transcription factor activity and multiomics-based classification into activators and repressors:diffTF. Cell Rep 29: 3147- 3159.e3112

[4] Buenrostro JD, Wu B, Chang HY, Greenleaf WJ (2015) ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr Protoc Mol Biol 109: 21.29.21- 21.29.29

[5] Cai Y, Zhou H, Zhu Y, Sun Q, Ji Y, Xue A, Wang Y, Chen W, Yu X, Wang L et al (2020) Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res 30: 574- 589

[6] Chan M, Yuan H, Soifer I, Maile TM, Wang RY, Ireland A, O’Brien J, Chan L, Vijay T et al (2021) Revisiting the hayflick limit: insights from an integrated analysis of changing transcripts, proteins, metabolites and chromatin. bioRxiv. https://doi.org/10.1101/2021.05.03.442497v1.abstract

[7] Collin G, Huna A, Warnier M, Flaman JM, Bernard D (2018) Transcriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence. Cell Death Dis 9: 259

[8] Colombo AR, Elias HK, Ramsingh G (2018) Senescence induction universally activates transposable element expression. Cell Cycle 17: 1846- 1857

[9] Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6: 2853- 2868

[10] Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, Satpathy AT, Rubin AJ, Montine KS, Wu B et al (2017) An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods 14: 959- 962

[11] De Cecco M, Ito T, Petrashen AP, Elias AE, Skvir NJ, Criscione SW, Caligiana A, Brocculi G, Adney EM, Boeke JD et al (2019) L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 566: 73- 78

[12] Eren M, Boe AE, Klyachko EA, Vaughan DE (2014) Role of plasminogen activator inhibitor-1 in senescence and aging. Semin Thromb Hemost 40: 645- 651

[13] Feng H, Conneely KN, Wu H (2014) A Bayesian hierarchical model to detect differentially methylated loci from single nucleotide resolution sequencing data. Nucleic Acids Res 42: e69

[14] Garneau H, Paquin MC, Carrier JC, Rivard N (2009) E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells. J Cell Physiol 221: 350- 358

[15] Guan Y, Zhang C, Lyu G, Huang X, Zhang X, Zhuang T, Jia L, Zhang L, Zhang C, Li C et al (2020) Senescence-activated enhancer landscape orchestrates the senescence-associated secretory phenotype in murine fibroblasts. Nucleic Acids Res 48: 10909- 10923

[16] Hänzelmann S, Beier F, Gusmao EG, Koch CM, Hummel S, Charapitsa I, Joussen S, Benes V, Brümmendorf TH, Reid G et al (2015) Replicative senescence is associated with nuclear reorganization and with DNA methylation at specific transcription factor binding sites. Clin Epigenet 7: 19

[17] Hernandez-Segura A, Nehme J, Demaria M (2018) Hallmarks of cellular senescence. Trends Cell Biol 28: 436- 453

[18] Hernando-Herraez I, Evano B, Stubbs T, Commere PH, Jan Bonder M, Clark S, Andrews S, Tajbakhsh S, Reik W (2019) Ageing affects DNA methylation drift and transcriptional cell-to-cell variability in mouse muscle stem cells. Nat Commun 10: 4361

[19] Hsu J, Sage J (2016) Novel functions for the transcription factor E2F4 in development and disease. Cell Cycle 15: 3183- 3190

[20] Hsu J, Arand J, Chaikovsky A, Mooney NA, Demeter J, Brison CM, Oliverio R, Vogel H, Rubin SM, Jackson PK et al (2019) E2F4 regulates transcriptional activation in mouse embryonic stem cells independently of the RB family. Nat Commun 10: 2939

[21] Humbert PO, Rogers C, Ganiatsas S, Landsberg RL, Trimarchi JM, Dandapani S, Brugnara C, Erdman S, Schrenzel M, Bronson RT et al (2000) E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell 6: 281- 291

[22] Iwafuchi-Doi M, Zaret KS (2014) Pioneer transcription factors in cell reprogramming. Genes Dev 28: 2679- 2692

[23] Ji Z, He L, Regev A, Struhl K (2019) Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers. Proc Natl Acad Sci USA 116: 9453- 9462

[24] Joung J, Konermann S, Gootenberg JS, Abudayyeh OO, Platt RJ, Brigham MD, Sanjana NE, Zhang F (2017) Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc 12: 828- 863

[25] Kurppa KJ, Liu Y, To C, Zhang T, Fan M, Vajdi A, Knelson EH, Xie Y, Lim K, Cejas P et al (2020) Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway. Cancer Cell 37: 104- 122

[26] Li Z, Schulz MH, Look T, Begemann M, Zenke M, Costa IG (2019) Identification of transcription factor binding sites using ATACseq. Genome Biol 20: 45

[27] Maehara K, Yamakoshi K, Ohtani N, Kubo Y, Takahashi A, Arase S, Jones N, Hara E (2005) Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53. J Cell Biol 168: 553- 560

[28] Marquard S, Thomann S, Weiler SME, Bissinger M, Lutz T, Sticht C, Tóth M, de la Torre C, Gretz N, Straub BK et al (2020) Yesassociated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis. Cell Commun Signal 18: 166

[29] Marti P, Stein C, Blumer T, Abraham Y, Dill MT, Pikiolek M, Orsini V, Jurisic G, Megel P, Makowska Z et al (2015) YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors. Hepatology 62: 1497- 1510

[30] Martínez-Zamudio RI, Roux PF, de Freitas J, Robinson L, Doré G, Sun B, Belenki D, Milanovic M, Herbig U, Schmitt CA et al (2020) AP-1 imprints a reversible transcriptional programme of senescent cells. Nat Cell Biol 22: 842- 855

[31] Minteer C, Morselli M, Meer M, Cao J, Lang S, Pellegrini M, Yan Q, Levine M (2020) A DNAmRep epigenetic fingerprint for determining cellular replication age. bioRxiv

[32] Nelson DM, McBryan T, Jeyapalan JC, Sedivy JM, Adams PD (2014) A comparison of oncogene-induced senescence and replicative senescence: implications for tumor suppression and aging. Age 36: 9637

[33] Potocki L, Kuna E, Filip K, Kasprzyk B, Lewinska A, Wnuk M (2019) Activation of transposable elements and genetic instability during long-term culture of the human fungal pathogen Candida albicans. Biogerontology 20: 457- 474

[34] Purcell M, Kruger A, Tainsky MA (2014) Gene expression profiling of replicative and induced senescence. Cell Cycle 13: 3927- 3937

[35] Qu K, Zaba LC, Satpathy AT, Giresi PG, Li R, Jin Y, Armstrong R, Jin C, Schmitt N, Rahbar Z et al (2017) Chromatin accessibility landscape of cutaneous T cell lymphoma and dynamic response to HDAC inhibitors. Cancer Cell 32: 27- 41

[36] Sanokawa-Akakura R, Akakura S, Ostrakhovitch EA, Tabibzadeh S (2019) Replicative senescence is distinguishable from DNA damage-induced senescence by increased methylation of promoter of rDNA and reduced expression of rRNA. Mech Ageing Dev 183: 111149

[37] Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131- 136

[38] Sherwood RI, Hashimoto T, O’Donnell CW, Lewis S, Barkal AA, van Hoff JP, Karun V, Jaakkola T, Gifford DK (2014) Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape. Nat Biotechnol 32: 171- 178

[39] Spitz F, Furlong EE (2012) Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 13: 613- 626

[40] Uluçkan Ö, Guinea-Viniegra J, Jimenez M, Wagner EF (2015) Signalling in inflammatory skin disease by AP-1 (Fos/Jun). Clin Exp Rheumatol 33: S44- 49

[41] van Deursen JM (2014) The role of senescent cells in ageing. Nature 509: 439- 446

[42] Vaughan DE, Rai R, Khan SS, Eren M, Ghosh AK (2017) Plasminogen activator inhibitor-1 is a marker and a mediator of senescence. Arterioscler Thromb Vasc Biol 37: 1446- 1452

[43] Wagner W, Bork S, Horn P, Krunic D, Walenda T, Diehlmann A, Benes V, Blake J, Huber FX, Eckstein V et al (2009) Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS ONE 4: e5846

[44] Wagner W, Fernandez-Rebollo E, Frobel J (2016) DNA-methylation changes in replicative senescence and aging: two sides of the same coin? Epigenomics 8: 1- 3

[45] Wang J, Zibetti C, Shang P, Sripathi SR, Zhang P, Cano M, Hoang T, Xia S, Ji H, Merbs SL et al (2018) ATAC-Seq analysis reveals a widespread decrease of chromatin accessibility in age-related macular degeneration. Nat Commun 9: 1364

[46] Wong ES, Schmitt BM, Kazachenka A, Thybert D, Redmond A, Connor F, Rayner TF, Feig C, Ferguson-Smith AC, Marioni JC et al (2017) Interplay of cis and trans mechanisms driving transcription factor binding and gene expression evolution. Nat Commun 8: 1092

[47] Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, Inman CL, Ogrodnik MB, Hachfeld CM, Fraser DG et al (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24: 1246- 1256

[48] Yu FX, Zhao B, Guan KL (2015) Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163: 811- 828

[49] Zhang C, Zhang X, Huang L, Huang X, Tian XL, Zhang L, Tao W (2021) ATF3 drives senescence by reconstructing accessible chromatin profiles. Aging Cell 20: e13315

RIGHTS & PERMISSIONS

2022 The Author(s)